English
Русский
Page Header
Pediatric Hematology/Oncology and Immunopathology
ISSN 1726-1708 (Print) ISSN 2414-9314 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Team
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Articles in press
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Search
Browse
  • By Issue
  • By Author
  • By Title
  • By Sections
Keywords acute lymphoblastic leukemia acute myeloid leukemia adolescents allogeneic hematopoietic stem cell transplantation bleeding chemotherapy children diagnosis flow cytometry hematopoietic stem cell transplantation hemophilia A minimal residual disease neuroblastoma platelets primary immunodeficiency prognosis relapse survival thrombosis treatment дети
×
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Search
Browse
  • By Issue
  • By Author
  • By Title
  • By Sections
Keywords acute lymphoblastic leukemia acute myeloid leukemia adolescents allogeneic hematopoietic stem cell transplantation bleeding chemotherapy children diagnosis flow cytometry hematopoietic stem cell transplantation hemophilia A minimal residual disease neuroblastoma platelets primary immunodeficiency prognosis relapse survival thrombosis treatment дети
Home > Search > Author Details

Author Details

Osipova, D. S.

Issue Section Title File
Vol 22, No 1 (2023) CLINICAL OBSERVATIONS Resistance to BRAF inhibitors in a patient with BRAF V600E-positive Langerhans cell histiocytosis PDF
(Rus)
Vol 22, No 1 (2023) PROMISING STUDIES The use of droplet digital polymerase chain reaction for the molecular diagnosis and monitoring of treatment response in patients with Langerhans cell histiocytosis with the BRAF V600E mutation PDF
(Rus)
Vol 22, No 4 (2023) ORIGINAL ARTICLES Clinicogenomic associations in patients with Langerhans cell histiocytosis: a cohort study PDF
(Rus)
Vol 23, No 1 (2024) ORIGINAL ARTICLES The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with BRAFV600E mutation PDF
(Rus)
Vol 23, No 2 (2024) ORIGINAL ARTICLES Experience in manufacturing a haploidentical biomedical cell product enriched with regulatory T-lymphocytes PDF
(Rus)

Developed by ECO-VECTOR

Powered by EVESYST

 
TOP